A study recently published in Frontiers provides new insight into the psychology of raves.
Psychedelics
MINDCURE Positioned For Strong Run In 2022 – CEO Q&A
MINDCURE's President and CEO, Kelsey Ramsden updates investors on iSTRYM's launch and rapid penetration, as well as drug development news on several fronts.
Cybin Announces Positive CYB003 Data Demonstrating Significant Advantages Over Oral Psilocybin for Treatment of Mental Health
CYB003 is demonstrating superior treatment properties vs. an oral dosage of psilocybin.
MINDCURE’s Update Hints At Big Things To Come
As MINDCURE's iSTRYM digital therapeutics platform rapidly gathers momentum, the company looks poised to join the emerging rally in the sector.
Novamind Reports FY2021 Financial Results and Operating Highlights
Novamind reports its full year results for fiscal 2021, including industry-leading revenue of CAD$6 million.
MINDCURE Provides Update on Studies and Clinical Trials
Mind Cure Health Inc., is pleased to provide an operational progress update on the strategic initiatives of its operating segments - MINDCURE Research and MINDCURE Technology.
Cybin Granted DEA Schedule I Manufacturing License
Cybin announces receiving its DEA Schedule I Manufacting License, necessary to work with Schedule I controlled substances in the U.S.
Wonderland: Miami Takes Shape as the Largest Psychedelic Medicine Business Event
On November 8 and 9, Miami, Florida will host Wonderland: Miami, the largest-ever business gathering in the psychedelic medicine sector, presented by Microdose, a guide to the business of psychedelics. Wonderland: Miami will be held at the Adrienne Arsht Center for the Performing Arts in Downtown Miami, Florida.
Bright Minds Biosciences Commences Trading on the Nasdaq Under the Ticker Symbol "DRUG"
Bright Minds Biosciences announces it has uplisted to the NASDAQ, trading under the symbol "DRUG".
Compass Pathways 2.0: A New Rally In Psychedelic Stocks?
Compass Pathways lifted the whole sector in 2020. With CMPS again rising, is history about to repeat?
Detroit Voters Approve Psychedelics Decriminalization Ballot Measure
Detroit voters approved a ballot initiative to widely decriminalize psychedelics, making it the latest in a growing number of jurisdictions to enact the reform.
Red Light Holland Appoints New Chief Financial Officer
Red Light Holland appoints a new Chief Financial Officer, David Ascott.
Psilocybin-assisted psychotherapy might help to reduce attachment anxiety
Scientists have begun to examine whether the psychedelic drug psilocybin, the active component of “magic” mushrooms, can help people who feel insecure in their attachments to others.
MINDCURE Signs LOI with Awakn Life Sciences to Distribute Ketamine Protocol for Alcohol Use Disorder into Clinics Across United States and Canada through iSTRYM, MINDCURE's Digital Therapeutics Platform
MINDCURE announces an LOI with Awaken Life Sciences for the deployment of MINDCURE's iSTRYM digital therapeutics platform in Awaken's addiction treatment clinics.